U.S. Recall Volume Surges to Near Record Highs in 2026 — Sedgwick Claims Management Services, Inc.

Event summary

U.S. recall volume reached 941.2 million units in H1 2026, on pace to exceed one billion units annually for only the fourth time in 15 years.
Recall events held steady at 1,634 in H1 2026, similar to H1 2025, but recalled units surged 345.5% year-over-year.
Pharmaceutical recalls skyrocketed 914.0% to 471.6 million units, and medical device recalls increased 516.8% to 313.1 million units in H1 2026.
USDA food recalls by volume climbed 2,432.1% to 37.2 million pounds, the third highest year recorded in over 15 years.
Regulatory bodies tightened enforcement on country-of-origin claims and imposed new restrictions on automotive imports from China.

The big picture

The dramatic increase in recall volume, particularly in pharmaceuticals and medical devices, signals a shift in the risk landscape where the scale and complexity of recalls pose greater threats than their frequency. Regulatory bodies are prioritizing enforcement, adding layers of complexity for businesses navigating geopolitical uncertainties and evolving trade partnerships. The data underscores the need for robust response plans and rapid communication strategies to mitigate operational, financial, and reputational risks.

What we're watching

Regulatory Headwinds: How tightening enforcement by the CPSC, USDA, FTC, and FDA will impact compliance costs and operational strategies for affected industries.
Industry-Specific Risks: Whether pharmaceutical and medical device companies can manage the surge in recalls without significant reputational or financial damage.
Geopolitical Complexity: The pace at which new trade restrictions and tariffs will reshape supply chains and product safety protocols for global companies.